Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 6/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | SCD | O00767 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | EGFR | P00533 | 3/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | HTR1D | P28221 | 1/20 | 0.38 |
| ▸ | HTR1B | P28222 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16102800 | 1.00 | KRAS (0.53) | KRASGAASCDMEN1KMT2A | |
| SCHEMBL16117727 | 0.94 | KRAS (0.50) | KRASGAASCDMEN1KMT2A | |
| SCHEMBL16117734 | 0.92 | KRAS (0.48) | KRASGAASCDMEN1KMT2A | |
| SCHEMBL16122843 | 0.92 | KRAS (0.51) | KRASGAASCDMEN1KMT2A | |
| SCHEMBL16122820 | 0.92 | KRAS (0.47) | KRASGAASCDEGFR | |
| SCHEMBL16122689 | 0.92 | KRAS (0.48) | KRASGAASCDKMT2AEGFR | |
| SCHEMBL16117783 | 0.90 | KRAS (0.48) | KRASGAASCDMEN1KMT2A | |
| SCHEMBL16122760 | 0.90 | KRAS (0.53) | KRASGAAMEN1KMT2AEGFR | |
| SCHEMBL16122813 | 0.90 | KRAS (0.53) | KRASGAAMEN1KMT2AEGFR | |
| SCHEMBL16117750 | 0.90 | KRAS (0.50) | KRASGAASCDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281607-A1 | MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER | TORAY INDUSTRIES, INC. (JP) | 2025-09-11 | — | — | US | disclosed |
| EP-4378478-A1 | MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER | Toray Industries, Inc. (JP) | 2024-06-05 | — | — | EP | disclosed |
| CN-116350613-B | Application of BMS-303141 in preparation of medicine for resisting gram-positive bacterial infection | 华中科技大学协和深圳医院 | 2024-03-15 | — | — | CN | disclosed |
| CN-117677398-A | Medicine for treating and/or preventing cancer | 东丽株式会社 | 2024-03-08 | — | — | CN | disclosed |
| CN-116350613-A | Application of BMS-303141 in preparation of medicine for resisting gram-positive bacterial infection | 华中科技大学协和深圳医院 | 2023-06-30 | — | — | CN | disclosed |
| WO-2023008462-A1 | MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER | 東レ株式会社 | 2023-02-02 | — | — | WO | disclosed |